News

Trump’s First Drug Negotiation Move Sparks Combo Medicine Fight
A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...
Ovarian Cancer Drugs Market To Hit $7.2 Billion By 2035, Driven By Rising FDA Approvals And 2024'S $4.2 Billion Base
Ovarian Cancer Drugs Market grows as FDA, EMA fast-track advanced-stage therapies, boosting global approvals and innovation. Anurag Tiwari Orion Market Research Pvt Ltd + +91 91798 28694 email us here ...
Stockhead20h
Health Check: Imugene goes to the well after reporting more blood cancer ‘cures’
Imugene is tapping the market for up to $35 million, while Clever Culture Systems and Compumedics are soaring on positive ...